P1321 : A phase 3B, double blind, placebo controlled study evaluating the effect of obeticholic acid on clinical outcomes in subjects with primary biliary cirrhosis at elevated risk of progression to liver transplant or death
| Autor: | Lindor, K., Hansen, B., Pencek, R., Hooshmand-Rad, R., Marmon, T., MacConell, L., Shapiro, D., Jones, D. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2015 62 Supplement 2:S850-S851 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect